A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects With Plaque Psoriasis
SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.3.2.11
Full Text
Open PDFAbstract
Available in full text
Date
March 11, 2019
Authors
Publisher
National Society for Cutaneous Medicine